3 hours Barclays Raises Travere Therapeutics (NASDAQ:TVTX) Price Target to $18.00 MarketBeat
Barclays boosted their price objective on shares of Travere Therapeutics from $14.00 to $18.00 and gave the company an “overweight” rating in a research report on Tuesday.